Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant.

Leukemia & lymphoma ·Vol. 54 ·No. 11 ·2013-11-00 ·Pages 2531-3

Arai S, Fanale M, DeVos S, Engert A, Illidge T, Borchmann P, Younes A, Morschhauser F, McMillan A, Horning SJ

Abstract

暂无摘要

MeSH Terms

Disease Progression Hematopoietic Stem Cell Transplantation Hodgkin Disease/mortality,therapy Humans Recurrence Transplantation, Autologous

Authors & Affiliations

10 authors, click to expand affiliations / ORCID

Arai Sally

Stanford University , Stanford, CA , USA.

Fanale Michelle

DeVos Sven

Engert Andreas

Illidge Tim

Borchmann Peter

Younes Anas

Morschhauser Franck

McMillan Alex

Horning Sandra J

Article Info

Journal

Leukemia & lymphoma

Abbr.

Leuk Lymphoma

ISSN

1029-2403

DOI

Published

2013-11-00

Epub

2013-00-05

Pages

2531-3

Language

English

Region

United States

NLM ID

9007422

Subset

External Links

Analysis Services